MDT

86.5

+0.42%↑

A

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

A

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

A

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

A

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

A

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

Search

Quidel Corp

Închisă

17.31 3.78

Rezumat

Modificarea prețului

24h

Curent

Minim

16.99

Maxim

17.31

Indicatori cheie

By Trading Economics

Venit

602M

-131M

Vânzări

24M

724M

Marjă de profit

-18.062

Angajați

6,500

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+78.26% upside

Dividende

By Dow Jones

Următoarele câștiguri

6 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-310M

899M

Deschiderea anterioară

13.53

Închiderea anterioară

17.31

Quidel Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

3 apr. 2026, 04:27 UTC

Evenimente importante

Singapore PM Warns That Fallout From Mideast War Could Outlast Conflict

5 apr. 2026, 23:55 UTC

Market Talk

Gold Falls Amid Dollar Strength, Inflation Worries -- Market Talk

5 apr. 2026, 23:45 UTC

Market Talk

Nikkei May Decline on Concerns About Energy Costs -- Market Talk

5 apr. 2026, 23:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

5 apr. 2026, 23:42 UTC

Market Talk

China's Consumer Inflation Likely Eased in March -- Market Talk

5 apr. 2026, 23:38 UTC

Market Talk
Evenimente importante

Oil Futures Rise Amid Increased Supply Disruption Concerns -- Market Talk

5 apr. 2026, 12:57 UTC

Evenimente importante

Some Italian Airports Report Jet-Fuel Shortages -- WSJ

3 apr. 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

3 apr. 2026, 18:30 UTC

Evenimente importante

An F15-E Just Went Down in Iran. What to Know About the $30 Million Jet. -- Barrons.com

3 apr. 2026, 18:14 UTC

Market Talk

Eli Lilly Seen as Possible GLP-1 Leader With New Pill Approval -- Market Talk

3 apr. 2026, 17:50 UTC

Market Talk

Microsoft's AI Development Will Weigh on Near-Term Azure Growth -- Market Talk

3 apr. 2026, 17:44 UTC

Achiziții, Fuziuni, Preluări

SBA Stock Just Had a Big Day. Why It's Suddenly Hot. -- Barrons.com

3 apr. 2026, 16:50 UTC

Evenimente importante

An F15-E Just Went Down in Iran. What to Know About the $90 Million Jet. -- Barrons.com

3 apr. 2026, 16:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

3 apr. 2026, 16:12 UTC

Câștiguri

Oil Stocks Look Tapped Out. Why It's Time to Move Into Other Sectors. -- Barrons.com

3 apr. 2026, 15:56 UTC

Market Talk
Evenimente importante

Crypto Markets May Be Active Over Holiday Weekend -- Market Talk

3 apr. 2026, 15:56 UTC

Market Talk
Evenimente importante

Global Equities Roundup: Market Talk

3 apr. 2026, 15:56 UTC

Market Talk
Evenimente importante

Global Forex and Fixed Income Roundup: Market Talk

3 apr. 2026, 15:20 UTC

Evenimente importante

Berkshire, Travelers Join U.S. Plan to Insure Shippers in the Hormuz Strait -- Barrons.com

3 apr. 2026, 15:08 UTC

Achiziții, Fuziuni, Preluări

OpenAI Makes Surprise Media Acquisition Ahead of IPO. Why It Will Fail. -- Barrons.com

3 apr. 2026, 14:11 UTC

Market Talk
Evenimente importante

Oil Shock From War in Iran May Show Up In 2Q Job Growth Data -- Market Talk

3 apr. 2026, 12:56 UTC

Market Talk

Treasury Yields, Dollar Higher Following Robust March Hiring -- Market Talk

3 apr. 2026, 08:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

3 apr. 2026, 08:01 UTC

Market Talk

Global Equities Roundup: Market Talk

3 apr. 2026, 08:01 UTC

Market Talk

Meituan's Profitability Likely to Improve This Year -- Market Talk

3 apr. 2026, 07:45 UTC

Market Talk

LG Electronics Could Post Above-Consensus 1Q Earnings -- Market Talk

3 apr. 2026, 06:17 UTC

Market Talk

Naver Likely to Post Below-Consensus 1Q Earnings -- Market Talk

3 apr. 2026, 06:17 UTC

Market Talk

Global Equities Roundup: Market Talk

3 apr. 2026, 04:33 UTC

Market Talk

China Merchants Port Earnings Likely to Recover This Year -- Market Talk

3 apr. 2026, 04:33 UTC

Market Talk

Global Equities Roundup: Market Talk

Comparație

Modificare preț

Quidel Corp Așteptări

Obiectiv de preț

By TipRanks

78.26% sus

Prognoză pe 12 luni

Medie 30.75 USD  78.26%

Maxim 38 USD

Minim 25 USD

În baza a 5 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruQuidel Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

5 ratings

1

Cumpărare

3

Păstrare

1

Vânzare

Date financiare

Cheltuieli de vânzare și administrare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

Profit operațional

$

Despre Quidel Corp

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.
help-icon Live chat